With any future Covid-19 vaccine requiring its manufacturing process to be signed off as part of its regulatory approval for use on the general population, Madeleine Finlay talks to Dr Stephen Morris from the Future Vaccine Manufacturing Research Hub about how vaccines are made at the volume and speed required for a mass vaccination programme
